Endovia Health Sciences, Inc.: sells 526,582 common shares for $81,830.84

What happened

• The filing reports that on Sep 30, 2026 the company sold and issued a total of 526,582 shares of common stock pursuant to that certain Securities Purchase Agreement dated Sep 19, 2025 with C/M Capital Master Fund, LP as purchaser (the “ELOC Agreement”) for total gross proceeds of $81,830.84.
• The ELOC Agreement was previously disclosed in the company’s Current Report on Form 8-K filed on Sep 25, 2025. To the extent the sales are deemed unregistered, the filing states they were made pursuant to the exemption under Section 4(a)(2) of the Securities Act and Rule 506(b). The purchaser’s resales of the shares were registered on the company’s Form S-1 (File No. 333-298112), effective Aug 24, 2026.

Key details

• 526,582 shares of common stock sold and issued on Sep 30, 2026
• Total gross proceeds of $81,830.84
• Sale pursuant to Securities Purchase Agreement dated Sep 19, 2025 with C/M Capital Master Fund, LP; agreement previously disclosed on Sep 25, 2025
• Resales registered on Form S-1 (File No. 333-298112), effective Aug 24, 2026; claimed exemption, if applicable, under Section 4(a)(2) and Rule 506(b)

Why it may matter

• This filing reports Item 3.02 (Unregistered sales of equity securities), which covers sales of the company’s equity that may rely on exemptions from registration.
• The filing does not show why the insider traded or why the company acted.